Clindamycin phosphate and Weight abnormal - a phase IV clinical study of FDA data

Summary:

Weight abnormal is reported as a side effect among people who take Clindamycin phosphate (clindamycin phosphate), especially for people who are female, 50-59 old, also take Proair Hfa, and have Narcolepsy.

The phase IV clinical study analyzes which people have Weight abnormal when taking Clindamycin phosphate. It is created by eHealthMe based on reports of 3,863 people who have side effects when taking Clindamycin phosphate from the FDA, and is updated regularly.

What is Clindamycin phosphate?

Clindamycin phosphate has active ingredients of clindamycin phosphate. It is often used in infection. eHealthMe is studying from 4,216 Clindamycin phosphate users. Check the latest studies of Clindamycin phosphate.

What is Weight abnormal?

Weight abnormal is found to be associated with 1,621 drugs and 1,298 conditions by eHealthMe. Check the latest studies of Weight abnormal.

On Jul, 10, 2026

3,863 people reported to have side effects when taking Clindamycin phosphate.
Among them, 14 people (0.36%) have Weight abnormal.

Could Clindamycin phosphate cause Weight abnormal?

Among these 14 people:

What is the gender of people who have Weight abnormal when taking Clindamycin phosphate? *

female: 76.92 %
male: 23.08 %

What is the age of people who have Weight abnormal when taking Clindamycin phosphate? *

What are other drugs people take besides Clindamycin phosphate? *

What are other side effects people have besides Weight abnormal? *

Rashes (redness): 4 people, 28.57%
Nausea (feeling of having an urge to vomit): 3 people, 21.43%
Drug Hypersensitivity: 3 people, 21.43%
White Blood Cell Count Decreased: 2 people, 14.29%
Blood Glucose Increased: 2 people, 14.29%
Drug Withdrawal Syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation): 2 people, 14.29%
Pain: 2 people, 14.29%
Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it): 2 people, 14.29%
Papilloma Viral Infection: 2 people, 14.29%
Loss Of Consciousness: 2 people, 14.29%

What are the existing conditions these people have? *

Cataplexy (loss of muscle tone accompanied by full conscious awareness): 6 people, 42.86%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 6 people, 42.86%
Drowsiness: 4 people, 28.57%
Depression: 4 people, 28.57%
Skin Abscess: 2 people, 14.29%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 14.29%
Irritable Bowel Syndrome: 2 people, 14.29%
Indigestion: 2 people, 14.29%
High Blood Pressure: 2 people, 14.29%
Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 2 people, 14.29%

* Approximation only. Some reports may have incomplete information.

Do you take Clindamycin phosphate and have Weight abnormal?

- Check whether Weight abnormal is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Clindamycin phosphate:

Clindamycin phosphate (4,216 reports)

Weight abnormal treatments and more:

Weight abnormal (2,837 reports)

Browse all side effects of Clindamycin phosphate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Weight abnormal:

Weight abnormal (1,621 drugs)

Browse all the conditions that are associated with Weight abnormal:

Weight abnormal (1,298 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on clindamycin phosphate (the active ingredients of Clindamycin phosphate) and Clindamycin phosphate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.